2012
DOI: 10.1089/end.2011.0140
|View full text |Cite
|
Sign up to set email alerts
|

Second Prize: Sustained Release Varnish Containing Chlorhexidine for Prevention of Biofilm Formation on Urinary Catheter Surface: In Vitro Study

Abstract: Of the various tested concentrations of sustained release varnishes, the 1% chlorhexidine concentration has demonstrated the superior antibiofilm effect on urinary catheters with P. aeruginosa. Although similar varnishes are used in dentistry, it needs extended research in animals before applying this technology in human trials.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
18
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 31 publications
0
18
0
Order By: Relevance
“…The catheters were coated with SRV prepared as previously described . Briefly, ethyl cellulose (5 g), polyethylene glycol (4 g), and chlorhexidine to a final concentration of 1% were dissolved in 100 mL of ethanol.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…The catheters were coated with SRV prepared as previously described . Briefly, ethyl cellulose (5 g), polyethylene glycol (4 g), and chlorhexidine to a final concentration of 1% were dissolved in 100 mL of ethanol.…”
Section: Methodsmentioning
confidence: 99%
“…The varnish was prepared by dissolving the active ingredient and the polymers until a homogeneous preparation was achieved . The SRV was applied to the catheters by a brush as an outer coat, resulting in a uniform coat on the catheters as previously demonstrated . After application, the solvent (ethanol) was allowed to evaporate and the coat remained as a uniform cover of the catheter.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Although silver and nitrofural functionalized catheters were shown in a multicenter randomized clinical trial to offer little or no clinical benefit, at least for short-term (14 days) catheterization, 24 catheters coated with a CHX varnish have been reported, [25][26][27] and the early laboratory and animal data are encouraging, 28 showing a reduction in biofilm formation with the CHX-coated devices.…”
mentioning
confidence: 99%